UNSPSC 51102840: Colistin/hydrocortisone/neomycin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class OT250. This VA Drug Class (OT250) classifies this compound as belonging to the group ANTI-INFECTIVE/ANTI-INFLAMMATORY COMBINATIONS, TOPICAL OTIC.

UNSPSC 51102840 Colistin/hydrocortisone/neomycin is a Commodity code that in recent state and local practice covers pharmaceutical products supplied through cooperative purchasing vehicles and direct procurement contracts for health and emergency-response agencies. The code's nominal scope names a specific combination antibiotic-corticosteroid formulation, but recent opportunities show state and local governments buying a broader range of pharmaceutical inventory — antibiotics (doxycycline, ciprofloxacin), opioid antagonists (naloxone), and related medical supplies — through both piggyback agreements on established state contracts and open competitive bids. Issuing bodies include state departments of public health procuring through multi-state consortia for strategic national stockpile supply, county health departments, and county emergency-response programs. The purchasing vehicle mix reflects the dual paths typical of pharmaceutical procurement: Illinois Department of Public Health used the MMCAP Infuse cooperative purchasing consortium for a three-year pharmaceutical warehouse order, while Seminole County, Florida issued an IFB for direct purchase of naloxone and drug deactivation systems.

Recent activity shows concentration in Florida and Illinois. The Illinois Department of Public Health awarded a three-year piggyback contract to Chartwell Rx LLC on August 28, 2026 for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets totaling $2,999,999.11 over all renewal periods through the MMCAP Infuse consortium, with an initial 12-month term and options for years 2 and 3. Seminole County, Florida released an IFB on June 30, 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023 and a two-year initial term plus one-year renewal option. Both solicitations require vendors to manage delivery logistics and comply with drug-free workplace and E-Verify requirements.